An overview of the inactivation of FMDV and the implications when residual virus is present in vaccines. Brown, F. In Developments in Biological Standardization, volume 75, pages 37-41, 1991.
bibtex   
@inproceedings{
 title = {An overview of the inactivation of FMDV and the implications when residual virus is present in vaccines},
 type = {inproceedings},
 year = {1991},
 identifiers = {[object Object]},
 pages = {37-41},
 volume = {75},
 id = {63848f1c-2c05-3072-97c0-d5abae47a9e7},
 created = {2020-09-30T20:09:25.368Z},
 accessed = {2020-09-30},
 file_attached = {false},
 profile_id = {f7328406-3e7e-3e37-9ea0-01d7cb781b09},
 group_id = {3455ce01-3ebd-33b1-bddf-c7304973b8e6},
 last_modified = {2020-09-30T20:09:25.580Z},
 read = {false},
 starred = {false},
 authored = {false},
 confirmed = {false},
 hidden = {false},
 folder_uuids = {9a808871-8498-4eda-bd89-d4a475cdd385},
 private_publication = {false},
 bibtype = {inproceedings},
 author = {Brown, F.},
 booktitle = {Developments in Biological Standardization}
}

Downloads: 0